Correction to : Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria (Antibiotics, (2024), 13, 9, (874), 10.3390/antibiotics13090874)
Kirkegaard, Cristina (Universitat Autònoma de Barcelona. Departament de Medicina)
del Barrio-Tofiño, Ester (Hospital Universitari Vall d'Hebron)
Villamarín, Miguel (Hospital Universitari Vall d'Hebron)
Larrosa, María Nieves (Universitat Autònoma de Barcelona. Departament de Medicina)
Campany, David (Hospital Universitari Vall d'Hebron)
González-López, Juanjo 1975- (Universitat Autònoma de Barcelona. Departament de Medicina)
Ferrer, Ricard (Universitat Autònoma de Barcelona. Departament de Medicina)
Viñado, Belén (Hospital Universitari Vall d'Hebron)
Doménech, Laura (Hospital Universitari Vall d'Hebron)
Sellarès-Nadal, Julia (Universitat Autònoma de Barcelona. Departament de Medicina)
Escolà-Vergé, Laura (Institut de Recerca Sant Pau)
Fernández-Hidalgo, Nuria (Universitat Autònoma de Barcelona. Departament de Medicina)
Los-Arcos, Ibai (Universitat Autònoma de Barcelona. Departament de Medicina)

Date:	2025
Abstract:	In the original publication [1], there was a mistake in Table 2, published as follows: Patients 1 and 23 presented clinical failure at day 14, as reported in the text. In addition, by error patient 23 should also appear as mortality at day 30: Yes, and patient 24 mortality at day 30 should be No. The corrected version of Table 2 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated. Demographic, clinical, and outcome characteristics of the 34 patients with infections caused by VIM-type-producing Gram-negative bacteria treated with cefiderocol. Abbreviations: allo-HSCT, allogeneic hematopoietic stem cell transplantation; CCI, Charlson comorbidity index; ECMO, extracorporeal membrane oxygenation; F, female; M, male; UTI, urinary tract infection; and COPD, chronic obstructive pulmonary disease.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Metallo-β-lactamase ; Siderophore ; Multidrug resistant ; Extremely drug resistant ; Carbapenemase
Published in:	Antibiotics, Vol. 14 Núm. 1 (1 2025) , p. 4, ISSN 2079-6382

Article original: https://ddd.uab.cat/record/306053?ln=ca
Erratum: https://ddd.uab.cat/record/320405
DOI: 10.3390/antibiotics14010004
PMID: 39858394

5 p, 178.6 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles